Compounds > nelfinavir
Page last updated: 2024-08-24

nelfinavir and Pancreatitis

nelfinavir has been researched along with Pancreatitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Algeciras-Schimnich, A; Badley, AD; Bren, GD; Chari, ST; Dawra, RK; Navina, S; Rizza, SA; Saluja, AK; Schnepple, D; Singh, VP; Vege, SS1
Badley, AD; Bennett, SA; Vlahakis, SR; Whitehead, SN1
Benhamou, Y; Bernard, B; Bricaire, F; Di Martino, V; Ezenfis, J; Opolon, P; Poynard, T1
Highleyman, L1

Reviews

1 review(s) available for nelfinavir and Pancreatitis

ArticleYear
HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo.
    Apoptosis : an international journal on programmed cell death, 2007, Volume: 12, Issue:5

    Topics: Animals; Apoptosis; Hippocampus; HIV Infections; HIV Protease Inhibitors; Humans; Mitochondrial ADP, ATP Translocases; Nelfinavir; Pancreatitis; Ritonavir; Signal Transduction; Stroke; T-Lymphocytes

2007

Other Studies

3 other study(ies) available for nelfinavir and Pancreatitis

ArticleYear
Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis.
    American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:5

    Topics: Amylases; Animals; Apoptosis; Caspase 3; Ceruletide; Cytochromes c; Disease Models, Animal; Drug Therapy, Combination; HIV Protease Inhibitors; Inflammation Mediators; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Necrosis; Nelfinavir; Pancreas; Pancreatitis; Ritonavir; Trypsin

2009
Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge.
    AIDS (London, England), 1999, Jul-30, Volume: 13, Issue:11

    Topics: Adult; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Male; Nelfinavir; Pancreatitis; Reverse Transcriptase Inhibitors

1999
New dosing of ddI (Videx) and Nelfinavir (Viracept) approved.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1999, Volume: 12, Issue:4

    Topics: Anti-HIV Agents; Didanosine; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir; Pancreatitis; United States Food and Drug Administration

1999